329 related articles for article (PubMed ID: 11275983)
1. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
4. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
6. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
[TBL] [Abstract][Full Text] [Related]
9. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
10. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.
Birch BD; Johnson JP; Parsa A; Desai RD; Yoon JT; Lycette CA; Li YM; Bruce JN
Neurosurgery; 1996 Jul; 39(1):135-40. PubMed ID: 8805149
[TBL] [Abstract][Full Text] [Related]
11. A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor.
Yokota T; Tachizawa T; Fukino K; Teramoto A; Kouno J; Matsumoto K; Emi M
J Hum Genet; 2003; 48(11):598-602. PubMed ID: 14566482
[TBL] [Abstract][Full Text] [Related]
12. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
[TBL] [Abstract][Full Text] [Related]
13. Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma.
Urioste M; Martínez-Ramírez A; Cigudosa JC; Colmenero I; Madero L; Robledo M; Martínez-Delgado B; Benítez J
Cancer Genet Cytogenet; 2002 Oct; 138(2):107-10. PubMed ID: 12505253
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic studies of pediatric ependymomas.
Kramer DL; Parmiter AH; Rorke LB; Sutton LN; Biegel JA
J Neurooncol; 1998 Mar; 37(1):25-33. PubMed ID: 9525835
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor.
Fukasawa T; Chong JM; Sakurai S; Koshiishi N; Ikeno R; Tanaka A; Matsumoto Y; Hayashi Y; Koike M; Fukayama M
Jpn J Cancer Res; 2000 Dec; 91(12):1241-9. PubMed ID: 11123422
[TBL] [Abstract][Full Text] [Related]
17. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
18. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas.
Slavc I; MacCollin MM; Dunn M; Jones S; Sutton L; Gusella JF; Biegel JA
Int J Cancer; 1995 Aug; 64(4):243-7. PubMed ID: 7657387
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
20. A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.
Zemmoura I; Vourc'h P; Paubel A; Parfait B; Cohen J; Bilan F; Kitzis A; Rousselot C; Parker F; François P; Andres CR
Neuro Oncol; 2014 Jan; 16(2):250-5. PubMed ID: 24357459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
